Zacks Research Analysts Increase Earnings Estimates for IDEX

Key Points

• Zacks Research raised its IDEX earnings estimates, projecting $2.13 EPS for Q1 2027, up from $2.12, with FY2027 and FY2028 estimates of $9.29 and $10.58 per share, respectively.
• IDEX recently exceeded expectations, reporting $2.32 EPS versus the $2.11 consensus and revenue of $920.6 million, up 6.4% year over year. Analysts maintain a “Moderate Buy” consensus rating with an average price target of $260.27.
• IDEX shares opened at $229.74, while institutional investors own 97.96% of the stock. The company also declared a quarterly dividend of $0.73 per share, equivalent to a 1.3% annualized yield.

IDEX Corporation (NYSE:IEX - Free Report) - Zacks Research upped their Q1 2027 earnings per share estimates for shares of IDEX in a report issued on Thursday, October 1st. Zacks Research analyst Team now anticipates that the industrial products company will earn $2.13 per share for the quarter, up from their prior forecast of $2.12. The consensus estimate for IDEX's current full-year earnings is $8.83 per share. Zacks Research also issued estimates for IDEX's Q2 2027 earnings at $2.35 EPS, Q4 2027 earnings at $2.43 EPS, FY2027 earnings at $9.29 EPS, Q1 2028 earnings at $2.39 EPS, Q2 2028 earnings at $2.46 EPS, Q3 2028 earnings at $2.77 EPS and FY2028 earnings at $10.58 EPS.

IDEX (NYSE:IEX - Get Free Report) last issued its quarterly earnings results on Wednesday, July 29th. The industrial products company reported $2.32 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.11 by $0.21. The firm had revenue of $920.60 million during the quarter, compared to the consensus estimate of $905.38 million. IDEX had a return on equity of 15.69% and a net margin of 14.49%.The company's revenue for the quarter was up 6.4% on a year-over-year basis. During the same quarter last year, the company posted $2.07 EPS. IDEX has set its FY 2026 guidance at 8.700-8.850 EPS and its Q3 2026 guidance at 2.200-2.250 EPS.

Several other research firms have also recently weighed in on IEX. Vertical Research started coverage on shares of IDEX in a research report on Tuesday, September 8th. They set a "buy" rating and a $250.00 price objective on the stock. Stifel Nicolaus increased their target price on IDEX from $257.00 to $268.00 and gave the company a "buy" rating in a research note on Thursday, July 30th. Citigroup raised their price target on IDEX from $252.00 to $269.00 and gave the company a "buy" rating in a research report on Thursday, July 30th. DA Davidson lifted their price target on IDEX from $230.00 to $240.00 and gave the stock a "neutral" rating in a research note on Thursday, August 6th. Finally, Royal Bank Of Canada upped their price objective on IDEX from $261.00 to $280.00 and gave the stock an "outperform" rating in a report on Thursday, July 30th. Nine investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to MarketBeat.com, IDEX currently has a consensus rating of "Moderate Buy" and an average price target of $260.27.

IDEX Trading Up 0.8%

Shares of IDEX stock opened at $229.74 on Friday. The company has a debt-to-equity ratio of 0.46, a current ratio of 3.05 and a quick ratio of 2.15. IDEX has a 1 year low of $159.27 and a 1 year high of $243.80. The firm has a market cap of $16.94 billion, a PE ratio of 33.06, a PEG ratio of 2.58 and a beta of 0.97. The company has a 50 day simple moving average of $229.64 and a two-hundred day simple moving average of $217.24.

Institutional Investors Weigh In On IDEX

Several institutional investors have recently bought and sold shares of IEX. BlackRock Inc. purchased a new position in IDEX in the 2nd quarter worth approximately $1,301,393,000. Primecap Management Co. CA bought a new position in shares of IDEX in the second quarter worth approximately $748,951,000. Van ECK Associates Corp increased its stake in shares of IDEX by 3.3% in the fourth quarter. Van ECK Associates Corp now owns 1,976,856 shares of the industrial products company's stock worth $351,762,000 after buying an additional 63,699 shares during the period. Amundi increased its stake in shares of IDEX by 19.6% in the second quarter. Amundi now owns 1,458,979 shares of the industrial products company's stock worth $331,017,000 after buying an additional 239,579 shares during the period. Finally, Bank of America Corp DE raised its holdings in IDEX by 215.0% during the 1st quarter. Bank of America Corp DE now owns 1,094,101 shares of the industrial products company's stock valued at $207,387,000 after buying an additional 746,732 shares during the last quarter. 97.96% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at IDEX

In other news, CAO Lisa Anderson sold 385 shares of the firm's stock in a transaction dated Wednesday, August 12th. The stock was sold at an average price of $238.59, for a total transaction of $91,857.15. Following the transaction, the chief accounting officer directly owned 4,327 shares of the company's stock, valued at approximately $1,032,378.93. This trade represents a 8.17% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.50% of the stock is currently owned by insiders.

IDEX Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 16th. Shareholders of record on Friday, October 2nd will be given a dividend of $0.73 per share. This represents a $2.92 annualized dividend and a yield of 1.3%. The ex-dividend date is Friday, October 2nd. IDEX's dividend payout ratio is presently 42.01%.

About IDEX

IDEX Corporation NYSE: IEX is a diversified industrial company that designs, manufactures and sells engineered products and technologies used to move, control and monitor fluids. Its products serve a range of industrial, commercial and specialty applications where precision, reliability and performance are important.

The company operates through three primary segments: Fluid & Metering Technologies, Health & Science Technologies, and Fire & Safety/Diversified Products. Its offerings include pumps, valves, flow meters, compressors, dispensing equipment, precision fluidics components and related systems.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.